Mounjaro (Tirzepatide) for People With Diabetes or a Thyroid Condition
What it does, what the research shows, who should avoid it, and what to ask your doctor, explained plainly.
- Prescription medicine
- Once-weekly injection
- Type 2 diabetes & weight management
Medically reviewed by Dr Neelesh Kapoor, Diabetologist · Greater Noida West · Last reviewed
- Once a weekOne small injection under the skin, started on a low dose and raised in steps
- Doctor-guidedStarted, adjusted and reviewed by your doctor, with regular follow-ups
- Plus lifestyleIt supports healthy eating and activity. It does not replace them.
What is Mounjaro?
Tirzepatide copies two natural gut hormones, GIP and GLP-1, that help control blood sugar and appetite. It is given once a week as a small injection under the skin.
- More insulin when neededHelps the body release insulin when blood sugar is high.
- Slower stomach emptyingFood leaves the stomach more slowly, so you feel full for longer.
- Lower appetiteReduced hunger makes it easier to eat less and keep to a plan.
Where is it approved in India?
India's drug regulator (CDSCO) has approved the Mounjaro KwikPen as an add-on to diet and exercise for type 2 diabetes, obesity (BMI 30 or above) and overweight (BMI 27 or above) with at least one weight-related condition such as high blood pressure or high cholesterol. Mounjaro first became available in India in March 2025.
What does the research show?
In large trials, most people saw their blood sugar and weight come down.
- With type 2 diabetes: average blood sugar (HbA1c) fell by about 2 to 2.5 percentage points over 40 weeks.
- With obesity but no diabetes: people lost on average about 16% to 22% of their body weight over 72 weeks, compared with about 2% on a dummy injection (placebo).
These are averages from supervised trials with diet and activity advice. Your result may be different.
See the trial numbers
Type 2 diabetes: fall in HbA1c
1,879 adults, 40 weeks, compared with semaglutide 1 mg.
Average weight loss was 7.8 to 12.4 kg depending on dose. Source: SURPASS-2 (NEJM).
Obesity without diabetes: weight loss
2,539 adults, 72 weeks, compared with placebo.
Source: SURMOUNT-1 (NEJM).
If you have diabetes or a thyroid condition
Many patients have both. Here is what matters for each.
Diabetes
- Low blood sugar. The risk goes up if you also take insulin or certain diabetes tablets (sulfonylureas). Your doctor may lower those doses.
- Insulin. If you use insulin, it is injected separately and never mixed with Mounjaro.
- Eyes. If you have diabetic eye disease, your eyes need checking while blood sugar improves quickly.
- Kidneys. Vomiting or diarrhoea can cause dehydration, which can harm the kidneys.
Thyroid
- The one firm “no”. A personal or family history of medullary thyroid cancer (a rare type), or of a related inherited condition called MEN 2. An underactive thyroid or common thyroid lumps are not on the label's list of reasons to avoid it, but your doctor still reviews your history.
- Report these symptoms. A lump in the neck, trouble swallowing, breathlessness or hoarseness that does not go away.
- Thyroid tablets. Mounjaro slows stomach emptying, which can affect how oral medicines are absorbed. Tell your doctor if you take levothyroxine. Do not change timing or dose on your own.
- Weight and thyroid. Low thyroid function is commonly linked with weight gain, but treating it with levothyroxine does not cause clinically significant weight loss in most people. Weight needs its own plan.
Source for label points: US prescribing information. It also notes that routine blood tests or ultrasound are of uncertain value for spotting this cancer early.
How is it taken?
The usual approach is to start at 2.5 mg once a week and move up in 2.5 mg steps, no sooner than every four weeks, based on how well it is tolerated. Your doctor sets the dose and the pace. Never change it on your own.
- 2.5 mgstart
- 5 mg≥ 4 weeks
- 7.5 mg≥ 4 weeks
- 10 mg≥ 4 weeks
- 12.5 mg≥ 4 weeks
- 15 mgmaximum
Step schedule from the US prescribing information. The 15 mg dose is the label maximum for adults.
Side effects
The most common ones are digestive and usually mild to moderate, mostly while the dose is being raised.
In the diabetes trials, nausea affected roughly 12% to 18% of people and diarrhoea 12% to 17%. In the obesity trial, nausea affected 25% to 33%. Less common but serious problems include inflammation of the pancreas, gallbladder problems, and dehydration that can harm the kidneys.
Get medical help promptly for:
- Severe stomach pain that does not go away
- Repeated vomiting
- Yellowing of the skin or eyes
- A lump or swelling in the neck
Who should avoid it
- Medullary thyroid cancer history. A personal or family history of it, or of the inherited condition MEN 2. In animal studies it caused thyroid tumours in rats. It is not known whether it does so in people.
- Allergy to tirzepatide or any ingredient in it.
- Pregnancy. Pregnant women and anyone planning pregnancy. Animal studies suggest it may harm the baby.
- Oral contraceptive pills. The prescribing information advises a non-oral method, or an added barrier method, for four weeks after starting and after each dose increase.
What happens if you stop?
In a one-year trial, people who had lost weight on tirzepatide were randomly either continued on it or switched to a dummy injection. Most of those switched to the dummy injection regained a large share of the weight they had lost. Treatment is planned for the long term, alongside lasting changes to food, activity and sleep, and is reviewed regularly.
Why see a doctor first
Mounjaro is not a shortcut, and Dr Kapoor may also advise against it. A consultation covers:
- Weight, waist, blood pressure and HbA1c
- Thyroid, kidney and liver tests
- A review of every medicine you take, including thyroid tablets and insulin
- Family history, especially of thyroid cancer
- If advised: a dose plan, a diet and activity plan, and follow-ups to manage side effects
What to bring
- Previous reports, including thyroid tests (TSH) and HbA1c
- A list of all medicines and supplements
- Details of earlier weight-loss attempts
Related: Weight management · Diabetes care · Thyroid care
Talk to Dr Neelesh Kapoor
Diabetologist · Gaur City 2, Greater Noida West
Book An Appointment+Or call +91 98117 01303
Frequently asked questions
Is Mounjaro a diabetes medicine or a weight-loss injection?
It is approved in India for both type 2 diabetes and weight management. Which use applies to you depends on your health and your doctor's assessment.
Can I take Mounjaro if I have hypothyroidism?
An underactive thyroid (hypothyroidism) is not on the label's list of reasons to avoid it. The firm reason is a personal or family history of medullary thyroid cancer or MEN 2. Whether it suits you is your doctor's decision after reviewing your history and tests.
Will it affect my thyroid tablet (levothyroxine)?
The prescribing information says Mounjaro delays stomach emptying and may affect how oral medicines are absorbed. Tell your doctor you take thyroid tablets, and do not change the timing or dose yourself.
Will fixing my thyroid make me lose weight?
An underactive thyroid is commonly linked with weight gain, but bringing it back to normal with levothyroxine does not lead to big weight loss in most people. Weight usually needs its own plan.
Can I buy it without a prescription?
No. It should be started only after a doctor's assessment, and taken only on a doctor's prescription and under follow-up.
Is it the same as semaglutide?
No. Semaglutide (in Ozempic and Wegovy) copies one gut hormone, GLP-1. Tirzepatide copies two, GLP-1 and GIP. In one trial, tirzepatide lowered HbA1c and weight more than semaglutide 1 mg, but the right choice depends on the individual.
How long will I need it?
It is usually a long-term treatment. Stopping often leads to weight regain, so any plan to reduce or stop should be made with your doctor.
Do I still need to watch what I eat?
Yes. It is approved as an add-on to diet and exercise, not a replacement for them.